General Notices

• Notice of Informational Webinar on the NIGMS PREP Program PAR-20-066, "Postbaccalaureate Research Education Program (R25)"
  (NOT-GM-22-007)
  National Institute of General Medical Sciences
  

• Notice of Informational Webinar on the NIGMS IMSD and G-RISE Research Training Programs
  (NOT-GM-22-008)
  National Institute of General Medical Sciences
  

• Notice of Availability of Pre-Application Webinar Recording and FAQ for RFA-MH-22-100 Effectiveness and Implementation Research for Post-Acute Interventions to Optimize Long-Term Mental Health Outcomes in Low- and Middle-Income Countries
  (NOT-MH-22-065)
  National Institute of Mental Health
  

• Notice of Pre-Application Webinar for RFA-MH-22-120, "Pilot Practice-based Research for Primary Care Suicide Prevention (R34 Clinical Trial Optional)"
  (NOT-MH-22-070)
  National Institute of Mental Health
  

• Notice of Pre-Application Webinar for Cellular Senescence Network (SenNet) RFAs: RFA-RM-22-003, RFA-RM-22-004, RFA-RM-22-005
  (NOT-RM-22-004)
  Office of Strategic Coordination (Common Fund)
  

• Request for Information: Seeking Input from Cohort and Biorepository Researchers on Liquid Biopsy Studies for Early Cancer Detection
  (NOT-CA-22-010)
  National Cancer Institute
  

• Request for Information: Seeking Input from Technology Developers on Liquid Biopsy Studies for Early Cancer Detection
  (NOT-CA-22-011)
  National Cancer Institute
  

• Request for Information (RFI) on the NINR 2022-2026 Strategic Plan Framework
  (NOT-NR-22-001)
  National Institute of Nursing Research
  

Notice of Changes to Funding Opportunities

• Notice of Correction to PAR-21-035, Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trials Required)".
  (NOT-CA-22-012)
  National Cancer Institute
  

• Notice of Early Expiration of NOT-HL-20-755 "Notice of Special Interest (NOSI): Heart, lung, blood and sleep focused ancillary studies to large ongoing clinical studies"
  (NOT-HL-21-035)
  National Heart, Lung, and Blood Institute
  

• Notice of Change to Application Due Dates for PAR-21-281, "Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 - Clinical Trials Not Allowed)"
  (NOT-OD-22-020)
  NIH Basic Behavioral and Social Science Opportunity Network
  

• Notice of Change to Review Dates of PAR-22-054, Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
  (NOT-RM-22-003)
  Office of Strategic Coordination (Common Fund)
  

• Notice of Change to Receipt Date for CTSA Program Funding Opportunities: PAR-21-293 (UM1), PAR-21-336 (K12), PAR-21-340 (RC2), PAR-21-339 (R25), PAR-21-338 (T32), and PAR-21-337 (T32)
  (NOT-TR-22-007)
  National Center for Advancing Translational Sciences
  

• Notice of Change to Expansion of Eligibility of Optional Companion Applications for CTSA Program Funding Opportunities: PAR-21-293 (UM1), PAR-21-340 (RC2), PAR-21-339 (R25), PAR-21-338 (T32), and PAR-21-337 (T32)
  (NOT-TR-22-008)
  National Center for Advancing Translational Sciences
  

• Notice of Change to PI effort and eligibility of foreign components for PAR-21-336: Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
  (NOT-TR-22-009)
  National Center for Advancing Translational Sciences
  

Notices of Intent to Publish

• RESCINDED - Notice of Intent to Publish a Funding Opportunity Announcement for Improving Uptake and Use of the Dapivirine Vaginal Ring for HIV Prevention (R01 Clinical Trial Optional)
  (NOT-MH-22-020)
  National Institute of Mental Health
  Office of Research on Women's Health
  

• RESCINDED - Notice of Intent to Publish a Funding Opportunity Announcement for Improving Uptake and Use of the Dapivirine Vaginal Ring for HIV Prevention (R21 Clinical Trial Optional)
  (NOT-MH-22-021)
  National Institute of Mental Health
  Office of Research on Women's Health
  

• RESCINDED - Notice of Intent to Publish a Funding Opportunity Announcement for Improving Uptake and Use of the Dapivirine Vaginal Ring for HIV Prevention (R34 Clinical Trial Optional)
  (NOT-MH-22-022)
  National Institute of Mental Health
  Office of Research on Women's Health
  

Notices of Special Interest

• Notice of Special Interest: Administrative Supplements for Summer Research Experiences for Students and Science Teachers
  (NOT-ES-22-001)
  National Institute of Environmental Health Sciences
  Office of Research on Women's Health
  

• Notice of Special Interest (NOSI): Heart, Lung, Blood and Sleep Focused Ancillary Studies to Large Ongoing Clinical Studies (Revised)
  (NOT-HL-21-030)
  National Heart, Lung, and Blood Institute
  

• Notice of Special Interest: SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed)
  (NOT-NS-22-017)
  National Institute of Neurological Disorders and Stroke
  National Cancer Institute
  National Eye Institute
  National Institute on Aging
  National Institute of Dental and Craniofacial Research
  

Funding Opportunities

• Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
  (PAR-21-353)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): November 05, 2024
  
  

• Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R03 - Clinical Trial Optional)
  (PAR-21-354)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): November 16, 2024
  
  

• Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
  (PAR-21-355)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): November 16, 2024
  
  

• Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)
  (PAR-22-028)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): September 30, 2024
  
  

• Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)
  (PAR-22-030)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): June 07, 2024